Atlas Trials

Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma

Clinical trial NCT00101309 · UNKNOWN

Trial details

NCT number
NCT00101309
Sponsor
Milton S. Hershey Medical Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
NeuroblastomaSarcoma
Start date
2004-11-01
Primary completion
2007-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.